Keener R et al., Cell Genomics - A method-focused excerpt describing LIZS6-related experiments across multiple conditions (NoSk, LSFM) with quantitative readouts and protocol detail. Key terms: LIZS6, NoSk, LSFM, tzqom�t{z, moww.

Study Highlights:
The provided text documents experiments centered on LIZS6 across multiple platforms and experimental conditions such as NoSk and LSFM. Quantitative measurements and numeric readouts appear throughout the excerpt (for example values like 4.333 and 43.5359), and the manuscript emphasizes assay workflows and imaging approaches. The excerpt is rich in methodological detail but does not present explicit mechanistic interpretation in the available text.

Conclusion:
The excerpt details protocols, comparative conditions, and quantitative outputs for LIZS6-related experiments but does not provide a clear mechanistic or clinical conclusion in the truncated text.

Music:
Enjoy the music based on this article at the end of the episode.

Article title:
Human genetic variation reveals FCRL3 is a lymphocyte receptor for Yersinia pestis

First author:
Keener R

Journal:
Cell Genomics

DOI:
10.1016/j.xgen.2025.100917

Reference:
Keener R.M., Shi S., Dalapati T., Wang L., Reinoso-Vizcaino N.M., Luftig M.A., et al.. Human genetic variation reveals FCRL3 is a lymphocyte receptor for Yersinia pestis. Cell Genomics, 5, 100917. (2025). https://doi.org/10.1016/j.xgen.2025.100917

License:
This episode is based on an open-access article published under the Creative Commons Attribution 4.0 International License (CC BY 4.0) – https://creativecommons.org/licenses/by/4.0/

Support:
Base by Base – Stripe donations: https://donate.stripe.com/7sY4gz71B2sN3RWac5gEg00

Official website https://basebybase.com

On PaperCast Base by Base you'll discover the latest in genomics, functional genomics, structural genomics, and proteomics.

Episode link: https://basebybase.com/episodes/ep52-lizzs6-methods-measurements

QC:
This episode was checked against the original article PDF and publication metadata for the episode release published on 2025-06-22.

QC Scope:
- article metadata and core scientific claims from the narration
- excludes analogies, intro/outro, and music
- transcript coverage: Audited sections describe the host receptor mechanism (FCRL3 binding to Ig-like domain 1), the RS2282284/N721S variant and its effect on signaling, in vitro assays (Gentamicin protection with GFP-tagged bacteria and flow cytometry), and evolutionary/clinical implications including hepatitis C association and autoimmune
- transcript topics: FCRL3 as lymphocyte receptor for Yersinia pestis; RS2282284 / N721S SNP in FCRL3 and signaling disruption; Ig-like domain 1 binding and extracellular interactions; SYK recruitment and actin-mediated engulfment; FCRL5 redundancy in bacterial entry; High-throughput genome-wide association screen in LCLs

QC Summary:
- factual score: 10/10
- metadata score: 10/10
- supported core claims: 6
- claims flagged for review: 0
- metadata checks passed: 4
- metadata issues found: 0

Metadata Audited:
- article_doi
- article_title
- article_journal
- license

Factual Items Audited:
- FCRL3 mediates entry of Yersinia pestis into B cells via binding to the extracellular Ig-like domain 1, triggering intracellular signaling that leads to engulfment.
- The RS2282284 SNP (N721S) in FCRL3 disrupts the intracellular signaling cascade, blunting SYK recruitment and actin polymerization, thereby reducing bacterial internalization.
- The same N721S variant is associated with a markedly reduced risk of chronic hepatitis C infection.
- The protective allele is present at about 6% frequency in humans, suggesting balancing selection due to trade-offs with autoimmunity.
- Other variations in FCRL3 that alter signaling capacity are linked to autoimmune diseases such as rheumatoid arthritis and Graves disease.
- Limitations acknowledged: the mechanism was studied in immortalized B cells and in vitro systems; in vivo validation is needed.

QC result: Pass.